Quick Answer
P3 Health Partners Inc. reported Earnings Per Share Diluted of $45.26 (loss) per share for the year ending 2025.
- P3 Health Partners Inc. showed an increase of +16.3% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from P3 Health Partners Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2022: $0.25 (loss) per share | Q2 2022: $3.73 (loss) per share | Q3 2022: $0.27 (loss) per share | Q1 2023: $0.22 (loss) per share | Q2 2023: $0.09 (loss) per share | Q3 2023: $0.12 (loss) per share | Q1 2024: $7.86 (loss) per share | Q2 2024: $7.37 (loss) per share | Q3 2024: $15.70 (loss) per share | Q1 2025: $6.28 (loss) per share | Q2 2025: $6.23 (loss) per share | Q3 2025: $9.67 (loss) per share.
- Over the full 5 years of available data (2021 to 2025), P3 Health Partners Inc.'s Earnings Per Share Diluted has declined by 18,758.3%.
- Historical annual values: Fiscal year 2025: $45.26 (loss) per share | Fiscal year 2024: $54.06 (loss) per share | Fiscal year 2023: $0.63 (loss) per share | Fiscal year 2022: $6.50 (loss) per share | Fiscal year 2021: $0.24 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: